PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Transplant Infectious Diseases and Ajmera Transplant Centre, University Health Network, Toronto, Canada. Victoria.hall@uhn.ca.\', \'Transplant Infectious Diseases and Ajmera Transplant Centre, University Health Network, Toronto, Canada.\', \'National Microbiology Laboratory & Public Health Agency of Canada, Winnipeg, Canada.\', \'Department of Biochemistry, University Health Network, Toronto, Canada.\', \'Transplant Infectious Diseases and Ajmera Transplant Centre, University Health Network, Toronto, Canada. Deepali.kumar@uhn.ca.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1038/s41590-021-01126-6
?:doi
?:hasPublicationType
?:journal
  • Nature immunology
is ?:pmid of
?:pmid
?:pmid
  • 35115679
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 14.007
?:rankingScore_hIndex
  • 336
is ?:relation_isRelatedTo_publication of
?:title
  • Delayed-interval BNT162b2 mRNA COVID-19 vaccination enhances humoral immunity and induces robust T cell responses.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all